Nom du produit:N-[4-methyl-2-(3-oxo-3,4-dihydroquinoxalin-2-yl)phenyl]-4-nitrobenzene-1-sulfonamide
IUPAC Name:N-[4-methyl-2-(3-oxo-3,4-dihydroquinoxalin-2-yl)phenyl]-4-nitrobenzene-1-sulfonamide
- CAS:927542-74-3
- Formule moléculaire:C21H16N4O5S
- Pureté:95%+
- Numéro de catalogue:CM991526
- Poids moléculaire:436.44
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:927542-74-3
- Formule moléculaire:C21H16N4O5S
- Point de fusion:-
- Code SMILES:CC1=CC(=C(NS(=O)(=O)C2=CC=C(C=C2)[N+]([O-])=O)C=C1)C1=NC2=C(NC1=O)C=CC=C2
- Densité:
- Numéro de catalogue:CM991526
- Poids moléculaire:436.44
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.